Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I SAD/MAD Study of RO6889450 in Healthy Japanese Males
jRCT2080224516Phase 1Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ralmitaront (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Jan 2019; status: completed.
02
Drugs
ralmitaront
Beyond the preview
Go deeper on jRCT2080224516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224516.